Efficacy News and Research

RSS
Cytiva licenses advanced machine learning technology from Allen Institute

Cytiva licenses advanced machine learning technology from Allen Institute

Researchers shed new light on epigenetic changes associated with ADNP syndrome

Researchers shed new light on epigenetic changes associated with ADNP syndrome

Scientists create new mouse model of permanent neonatal diabetes

Scientists create new mouse model of permanent neonatal diabetes

Face masks protect from COVID-19 and other respiratory illnesses

Face masks protect from COVID-19 and other respiratory illnesses

HDAC6 inhibitors increase efficacy of immunotherapy in triple-negative breast cancer

HDAC6 inhibitors increase efficacy of immunotherapy in triple-negative breast cancer

New medical imaging resource center at UChicago will help tackle COVID-19 pandemic

New medical imaging resource center at UChicago will help tackle COVID-19 pandemic

NIH-Moderna investigational vaccine protects mice from infection with SARS-CoV-2

NIH-Moderna investigational vaccine protects mice from infection with SARS-CoV-2

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

New serological test for COVID-19 helps determine herd immunity, vaccine efficacy

Bisphosphonates may be safe and beneficial for osteoarthritis patients

Bisphosphonates may be safe and beneficial for osteoarthritis patients

European Commission approves first drug for hepatitis D

European Commission approves first drug for hepatitis D

New research project receives federal funding to expand treatment options for sickle cell patients

New research project receives federal funding to expand treatment options for sickle cell patients

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Scientists detect emergence and spread of artemisinin-resistant malaria parasites in Rwanda

Scientists detect emergence and spread of artemisinin-resistant malaria parasites in Rwanda

De novo protein decoys that block SARS-CoV-2

De novo protein decoys that block SARS-CoV-2

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Five alternative methods of SARS-CoV-2 suppression

Five alternative methods of SARS-CoV-2 suppression

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.